Lifetime Risk of Developing or Dying From Cancer
The lifetime risk of developing or dying from cancer refers to the chance a person has, over the course of their lifetime (from birth to death), of being diagnosed with or dying from cancer. These risk estimates are one way to measure how widespread cancer is in the United States.
The following tables list lifetime risks of developing and dying from certain cancers for men and women in the United States. The information is from the National Cancer Institute’s Surveillance Epidemiology and End Results (SEER) database,
Risk for developing cancer is based on incidence data from 201 8, 2019 , and 2021. Because of the impact of the COVID-19 pandemic, 2020 is not included .
Risk of dying from cancer is based on mortality data from 2020 through 2022 in the US, the most recent years for which data are available.
The risk is expressed both in terms of a percentage and as odds.
- For example, the risk that a man will develop cancer of the pancreas during his lifetime is 1.7%. This means he has about 1 chance in 60 of developing pancreatic cancer (100/1.7 is about 60).
- Put another way, 1 out of every 60 men in the United States will develop pancreatic cancer during his lifetime.
These numbers are average risks for the overall US population. Your risk may be higher or lower than these numbers, depending on your particular risk factors for each type of cancer.
The percentages in the tables below are rounded to the nearest tenth, although the actual numbers are more precise. This can lead to small discrepancies in the odds in some cases.
Males
Risk of developing |
Risk of dying from |
|||
% |
1 in |
% |
1 in |
|
Any cancer |
39.9 |
3 |
1 7.2 |
6 |
Bladder (includes in situ) |
3. 4 |
2 9 |
0.8 |
1 32 |
Brain and nervous system |
0.7 |
1 54 |
0.5 |
205 |
Breast |
0.1 |
7 55 |
<0.1 |
3,7 93 |
Colon and rectum |
4. 1 |
2 4 |
1. 5 |
6 7 |
Esophagus |
0.8 |
1 32 |
0. 6 |
1 58 |
Hodgkin lymphoma |
0.2 |
4 46 |
<0.1 |
3, 092 |
Kidney and renal pelvis |
2. 2 |
4 5 |
0.5 |
1 99 |
Larynx (voice box) |
0.5 |
21 1 |
0.2 |
637 |
Leukemia |
1. 8 |
5 5 |
0. 8 |
1 28 |
Liver and bile duct |
1.5 |
6 8 |
0 .9 |
10 8 |
Lung and bronchus |
5.8 |
1 7 |
3. 7 |
2 7 |
Melanoma of the skin* |
3. 5 |
2 9 |
0.4 |
2 69 |
Multiple myeloma |
1.0 |
10 8 |
0.4 |
24 9 |
Non-Hodgkin lymphoma |
2. 3 |
4 4 |
0.7 |
1 54 |
Oral cavity and pharynx |
1.7 |
61 |
0. 3 |
24 9 |
Pancreas |
1.7 |
60 |
1. 3 |
7 8 |
Prostate |
12. 8 |
8 |
2. 0 |
4 9 |
Stomach |
1.0 |
10 4 |
0. 3 |
2 92 |
Testicles |
0.4 |
24 8 |
<0.1 |
4, 625 |
Thyroid |
0. 6 |
1 6 0 |
0.1 |
1, 913 |
Females
Risk of developing |
Risk of dying from |
||||
% |
1 in |
% |
1 in |
||
Any cancer |
39. 0 |
3 |
1 6 |
6 |
|
Bladder (includes in situ) |
1.1 |
9 3 |
0.3 |
3 37 |
|
Brain and nervous system |
0.5 |
1 92 |
0.4 |
24 8 |
|
Breast |
13 .1 |
8 |
2. 3 |
4 3 |
|
Cervix |
0. 6 |
1 5 6 |
0.2 |
4 86 |
|
Colon and rectum |
3. 8 |
2 6 |
1. 4 |
7 2 |
|
Esophagus |
0.2 |
43 7 |
0.2 |
56 3 |
|
Hodgkin lymphoma |
0.2 |
5 36 |
<0.1 |
4, 355 |
|
Kidney and renal pelvis |
1. 3 |
7 5 |
0.3 |
3 56 |
|
Larynx (voice box) |
0.1 |
8 75 |
<0.1 |
2, 505 |
|
Leukemia |
1.3 |
7 7 |
0.6 |
1 70 |
|
Liver and bile duct |
0.7 |
143 |
0.5 |
18 5 |
|
Lung and bronchus |
5. 6 |
1 8 |
3. 5 |
2 9 |
|
Melanoma of the skin* |
2.5 |
4 0 |
0.2 |
4 96 |
|
Multiple myeloma |
0.8 |
13 3 |
0. 3 |
309 |
|
Non-Hodgkin lymphoma |
1.9 |
5 4 |
0. 5 |
1 85 |
|
Oral cavity and pharynx |
0.7 |
139 |
0.2 |
54 2 |
|
Ovary |
1.1 |
8 9 |
0. 7 |
1 40 |
|
Pancreas |
1.7 |
60 |
1.3 |
7 8 |
|
Stomach |
0.6 |
15 3 |
0. 2 |
405 |
|
Thyroid |
1.7 |
5 9 |
0.1 |
1, 513 |
|
Uterus |
3.1 |
32 |
0.7 |
15 4 |
|
*The risk numbers for melanoma are for non-Hispanic White people. The risk among people of other races/ethnicities is likely to be lower.
- Written by
- References
The American Cancer Society medical and editorial content team
Our team is made up of doctors and oncology certified nurses with deep knowledge of cancer care as well as editors and translators with extensive experience in medical writing.
American Cancer Society. Cancer Facts and Figures 2025. Atlanta: American Cancer Society; 2025.
Last Revised: January 30, 2025
American Cancer Society medical information is copyrighted material. For reprint requests, please see our Content Usage Policy.
American Cancer Society Emails
Sign up to stay up-to-date with news, valuable information, and ways to get involved with the American Cancer Society.
